Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis.

Black, RJ; Novakovic, D; Plit, M; Miles, A; MacDonald, P; Madill, C

Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis.

Black, RJ Novakovic, D Plit, M Miles, A MacDonald, P Madill, C

Permalink

Publisher:: Elsevier
Publication Type:: Journal Article
Citation:: Journal of Heart and Lung Transplantation, 2021, 40, (12), pp. 1483-1494
Issue Date:: 2021-12

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download full textAdobe PDF (1.07 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Black, RJ
dc.contributor.author	Novakovic, D
dc.contributor.author	Plit, M
dc.contributor.author	Miles, A
dc.contributor.author	MacDonald, P
dc.contributor.author	Madill, C
dc.date.accessioned	2022-01-09T23:28:24Z
dc.date.available	2021-08-19
dc.date.available	2022-01-09T23:28:24Z
dc.date.issued	2021-12
dc.identifier.citation	Journal of Heart and Lung Transplantation, 2021, 40, (12), pp. 1483-1494
dc.identifier.issn	0887-2570
dc.identifier.issn	1557-3117
dc.identifier.uri	http://hdl.handle.net/10453/152840
dc.description.abstract	Despite continued surgical advancements in the field of cardiothoracic transplantation, post-operative complications remain a burden for the patient and the multidisciplinary team. Lesser-known complications including swallowing disorders (dysphagia), and voice disorders (dysphonia), are now being reported. Such disorders are known to be associated with increased morbidity and mortality in other medical populations, however their etiology amongst the heart and lung transplant populations has received little attention in the literature. This paper explores the potential mechanisms of oropharyngeal dysphagia and dysphonia following transplantation and discusses optimal modalities of diagnostic evaluation and management. A greater understanding of the implications of swallowing and laryngeal dysfunction in the heart and lung transplant populations is important to expedite early diagnosis and management in order to optimize patient outcomes, minimize allograft injury and improve quality of life.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier
dc.relation.ispartof	Journal of Heart and Lung Transplantation
dc.relation.isbasedon	10.1016/j.healun.2021.08.006
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1102 Cardiorespiratory Medicine and Haematology
dc.subject.classification	Surgery
dc.title	Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis.
dc.type	Journal Article
utslib.citation.volume	40
utslib.location.activity	United States
utslib.for	1102 Cardiorespiratory Medicine and Haematology
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
pubs.consider-herdc	false
dc.date.updated	2022-01-09T23:28:23Z
pubs.issue	12
pubs.publication-status	Published
pubs.volume	40
utslib.citation.issue	12

Abstract:

Despite continued surgical advancements in the field of cardiothoracic transplantation, post-operative complications remain a burden for the patient and the multidisciplinary team. Lesser-known complications including swallowing disorders (dysphagia), and voice disorders (dysphonia), are now being reported. Such disorders are known to be associated with increased morbidity and mortality in other medical populations, however their etiology amongst the heart and lung transplant populations has received little attention in the literature. This paper explores the potential mechanisms of oropharyngeal dysphagia and dysphonia following transplantation and discusses optimal modalities of diagnostic evaluation and management. A greater understanding of the implications of swallowing and laryngeal dysfunction in the heart and lung transplant populations is important to expedite early diagnosis and management in order to optimize patient outcomes, minimize allograft injury and improve quality of life.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/152840